Table 1.

IFR: infection fatality rate; VIN: percentage of virus inactivated vaccines; ADV: percentage of adenovirus vaccines; RNA: percentage of RNA vaccines^20–25; $T_D$: decoupling time; % Nat-Inf: percentage of population naturally infected at $T_D$; % Vac: percentage of the population fully vaccinated at $T_D$; cHIT (conditional herd immunity threshold): percentage of immunized population due to vaccines and natural infections at $T_D$. The vaccine effectiveness (VE) against SARS-CoV-2 infections was adjusted to 66% for VIN, 73% for ADV and 93% for RNA^17,18.

Country	IFR	(VIN, ADV, RNA)	$T_D$	% Nat-Inf	% Vac	cHIT (%)
Argentina	0.67 (0.36-1.30)	(31.1, 64.7, 04.2)	Jun. 02	26 (13-48)	06	29 (17-52)
Brazil	0.59 (0.32-1.17)	(34.4, 48.1, 17.5)	Jun. 23	40 (20-74)	11	45 (25-79)
Chile	0.73 (0.40-1.43)	(71.1, 06.9, 22.0)	May 22	20 (10-37)	40	43 (34-60)
Paraguay	0.41 (0.23-0.83)	(11.6, 26.6, 61.8)	Jun. 11	35 (18-64)	02	36 (19-64)
Uruguay	0.90 (0.49-1.56)	(59.8, 01.6, 38.6)	May 29	13 (8-24)	29	33 (27-44)
Israel	0.65 (0.35-1.27)	(0,0,100)	Feb. 28	10 (5-19)	39	42 (37-51)
Italy	1.38 (0.73-2.60)	(0,14.3,85.7)	Apr. 29	22 (11-32)	10	31 (17-38)